ORGANIZATION STUDY AT BPRL PVT. LTD.

INDUSTRY PROFILE
The pharmaceutical industry discovers, develops, produces, and markets drugs or
pharmaceutical drugs for use as medications to be administered to patients (or self-
administered), with the aim to cure them, vaccinate them, or alleviate symptoms.
Pharmaceutical companies may deal in generic or brand medications and medical devices.
They are subject to a variety of laws and regulations that govern the patenting, testing, safety,
efficiency using drug testing and marketing of drugs.

1.1 INTRODUCTION
Bangalore Pharmaceuticals and Research Laboratory PVT LTD, also known as BPRL is a
young and fast growing pharmaceutical company based in Bangalore which is into
Development, Manufacturing and Marketing of quality Herbal and Nutraceutical products with
a world class manufacturing facility. The state-of-the-art facility meets international standards
in respect to safety, quality and environment control norms. Our manufacturing facility is
located on a 4.5 acre plot that is owned by BPRL.

“Coming together is a beginning; keeping together is progress; working together is success.”–

Edward Everett Hale.

In BPRL, we believe in adhering to sound business ethics coupled with a management ethos
that has a very high esteem for its people, imbibing a sense of belief in traditional values,
reliance on innovative technology and a strong dependence on modern management concepts.

1.2 FOUNDER
BPRL was created by an eminent Doctor, Late Dr.S. T. Mady who enjoyed the position of a
leading medical practitioner in the garden city of Bangalore. The company started its operations
by manufacturing and distributing common products required by the medical profession in
Bangalore. The Company got its impetus for growth when Late Dr. S.T. Mady was joined by

1
 ORGANIZATION STUDY AT BPRL PVT. LTD.

his sons Late Sri S.S Mady and Sri S.T.R Mady, currently, Chairman and Managing director
of the Company and Sri S Jayaprakash Mady, Director (son of late Sri S.S Mady).

1.3 FORMATION
Bangalore Pharmaceutical and Research Laboratory Private Limited was founded in the year
1957 by Dr. Sural Thammaiah Mady, also known as S. T. Mady, an eminent doctor, with an
ambition of manufacturing good quality medicinal products to the public. The company started
it's operations by manufacturing and distributing general medicines in Bengaluru.

It later got it's impetus for growth when Dr. S. T. Mady was joined by his sons Mr. S. S. Mady
and Mr. S. T. R. Mady, both qualified pharmacists.

Wintac Limited (earlier known as Recon Limited) was established in the year 1987. as an off-
shoot of BPRL Pvt. Ltd.

BPRL later involved itself into the field of herbal health care by acquiring SAGAR
Pharmaceuticals, a reputed name among Ayurvedic companies. The Ayurvedic expertise of
SAGAR Pharmaceuticals combined with BPRL's manufacturing & marketing expertise
reached the market with time tested products with tangible results which contains the science
of Ayurveda.

1.4 VISION, MISSION AND OBJECTIVES

VISION
To be a fast growing successful pharmaceutical company and earn reputation as a very reliable
partner for manufacturing and marketing of various pharmaceutical specialties.

We inspire and motivate our people; we recognize and reinforce their efforts and we envision,
engage and empower them.

2
 ORGANIZATION STUDY AT BPRL PVT. LTD.

MISSION
We are committed to meet the healthcare needs of the people, adhere to international
standards of quality, skills, competency and customer orientation. Promote research and
innovation for progress. Introducing quality and innovative products that enhance the lives of
our patients. Developing passionate and devoted employees who put their hearts and minds to
work in order to achieve the best results.

OBJECTIVES
 Expand R&D capabilities and develop a robust pipeline of innovative drugs: This
involves investing in research facilities, attracting top talent, and focusing on areas
with high unmet medical needs.
 Optimize manufacturing processes and ensure quality assurance: This includes
implementing efficient production methods, maintaining stringent quality control
standards, and complying with regulatory requirements.
 Strengthen brand reputation and increase marketing effectiveness: This involves
building consumer trust, establishing a strong brand identity, and effectively
communicating the value proposition of BPRL's products.
 Expand into new markets and segments: This includes exploring opportunities in
international markets, diversifying product offerings, and entering emerging segments
like biosimilars and biologics.
 Enhance digital capabilities and leverage technology: This involves adopting digital
tools for R&D, manufacturing, marketing, and customer service to improve efficiency
and effectiveness.
 Foster a culture of innovation and continuous improvement: This encourages
employee creativity, invests in training and development, and promotes an
environment of collaboration and learning.
 Promote corporate social responsibility and sustainability: This includes initiatives to
address environmental concerns, support communities, and contribute to social
development.

3
 ORGANIZATION STUDY AT BPRL PVT. LTD.

1.5 QUALITY POLICY AND AWARDS

QUALITY POLICY

With the help of its own research department, BPRL Pvt. Ltd. Is always pushing itself to the
limit to provide the top of the line quality products to its customers.

1. Commitment to Quality: BPRL has a long history of producing high-quality

pharmaceutical products, earning numerous awards and recognition for their adherence to
strict quality standards. This suggests a strong commitment to quality throughout their
operations, from sourcing raw materials to manufacturing and distribution.

2. Regulatory Compliance: BPRL adheres to national and international regulations like Good
Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). This implies a quality
policy that prioritizes compliance with regulatory requirements to ensure product safety and
efficacy.

3. Quality Control: BPRL likely has robust quality control systems in place to monitor and
ensure the quality of their products at every stage of production. This includes testing raw
materials, in-process controls, and finished product testing to meet predetermined
specifications.

AWARDS (Milestones/ Achievements)

Established in 1957, BPRL PVT LTD has a rich history of milestones and achievements in
the pharmaceutical industry. Here are some of the key highlights:

Early Years (1957-1970s):

1957: Founded by Dr. H.R. Rajendra, BPRL started as a small manufacturing unit producing
Ayurvedic medicines and tonics.

1960s: BPRL expanded its product portfolio to include allopathic medicines, becoming a
leading supplier to the Indian government.

4
 ORGANIZATION STUDY AT BPRL PVT. LTD.

1970s: BPRL established its reputation as a reliable manufacturer of high-quality

pharmaceutical products, gaining recognition for its innovative formulations and adherence to
strict quality standards.

Growth and Expansion (1980s-2000s):

1980s: BPRL entered the international market, exporting its products to countries in
Asia, Africa, and the Middle East.

1990s: BPRL invested heavily in research and development, establishing a dedicated R&D
facility and collaborating with leading universities and research institutions.

2000s: BPRL expanded its manufacturing capacity, setting up new plants and adopting
cutting-edge technologies to meet the growing demand for its products.

Recent Achievements (2010s-2020s):

2010s: BPRL received several national and international awards for its commitment to
quality and innovation.

2011: BPRL launched its first biosimilar drug, marking a significant step forward in its
technological advancement.

2012: BPRL was recognized as a "Star Export House" by the Government of India for its
outstanding export performance.

2013: BPRL received the "National Award for Research and Development" from the
Government of India.

2014: BPRL established a new research center dedicated to the development of novel drug
delivery systems.

2015: BPRL received the "CII Best Pharmaceutical Company Award" for its excellence in
manufacturing practices.

2016: BPRL launched its first biosimilar insulin product, expanding its portfolio of affordable
and high-quality biosimilar drugs.

5
 ORGANIZATION STUDY AT BPRL PVT. LTD.

2017: BPRL received the "Golden Peacock Award for Corporate Social Responsibility" for
its commitment to sustainable practices and community development.

2018: BPRL was ranked among the "Top 100 Pharmaceutical Companies in India" by The
Economic Times.

2019: BPRL received the "Pharma Excellence Award" from the Indian Drug Manufacturers'
Association (IDMA).

2020: BPRL launched its first COVID-19 vaccine candidate, demonstrating its dedication to
developing innovative solutions for global health challenges.

Additional Achievements:

BPRL has received numerous patents for its innovative products and processes.

BPRL is actively involved in various social responsibility initiatives, focusing on

healthcare, education, and environmental sustainability.

BPRL is a member of several prestigious industry associations, including the Indian

Pharmaceutical Association (IPA) and the Organization of Pharmaceutical Producers of India
(OPPI).

1.6 PRODUCT PROFILE

BPRL Pvt Ltd has a vast number of product available to the public. Some of its noteworthy

ones are:

1. Anuloma (Constipation & Indigestion) (Tablet & Churna)

 Anuloma regularizes the bowel movement.

 Anuloma makes the faeces soft and prevent hard stools, thus corrects constipation.
 Anuloma clears the gaseous distension as it contains carminatives.
 Anuloma prevents the griping effect non-habit forming and also safe for long term
use.
 Anuloma improves the complete digestive process and avoid anorexia.

6
 ORGANIZATION STUDY AT BPRL PVT. LTD.

2. Tonsari (Throat Irritation & Infection) (Capsule)

 Tonsari possesses analgesic and anti-inflammatory properties that relieves from pain
and inflammatory symptoms.
 Tonsari helps to overcome the infections caused by bacteria, virus and fungus.
 Tonsari possesses immunomodulatory property which potentiate the resistance and
repeated infections.

3. Stomatab (Mouth Ulcers) (Capsule)

 Stomatab capsule restores formation of epithelial mucosa in buccal cavity.

 Stomatab capsule possesses astringent and cooling properties that helps in quick
wound healing.
 Stomatab capsule provides resistance to further microbial attacks.
 Stomatab capsule acts as mild antacid, useful as refrigerant in GI disorders & urethral
disorders.
 Stomatab capsule formulated on the Ayurvedic principle of "Pitta dosha" offers an
alternative treatment for many types of mouth sores.

4. Nasollerin (Cold & Blockage of Nostrils) (Capsule)

 Nasollerin is a combination of drugs-Anti-inflammatory, Anti-allergic and Anti-

microbial properties.
 Nasollerin possesses immunomodulatory properties which protects the body against
allergies and improves the immunity.
 Nasollerin builds up resistance to infection and helps prevent re- infection.
 Nasollarin possesses mucolytic, antitussive and Anti-inflammatory properties that
clear the air ways and dissolve thick mucus accumulated in the lungs.

7
 ORGANIZATION STUDY AT BPRL PVT. LTD.

1.7 COMPETITORS PROFILE

 Sun Pharma

Sun Pharma is a multinational company which was established by Mr. Dilip Shanghavi in the
year 1983 offering products to treat psychiatry. Today the company has various formulations
in different therapeutic fields, which are cardiology, psychiatry, neurology, gastroenterology
and diabetology. It is India's largest pharmaceutical company in the industry with respect to
it's revenue. In the FY 2023 it's total revenue from operations was calculated to be
₹37,102.63 Cr.

 Divi's Laboratories

Divi's Laboratories Limited is an Indian origin pharmaceutical company established in the

year 1990 by Mr. Murali Divi. It is headquartered in Hyderabad, Telangana. Divi's Lab Ltd.
produces and custom synthesizes generic APIs, intermediates and nutraceutical ingredients.
The company's revenue for the FY 2023 was calculated to be at ₹7,500 Cr..

 Dr. Reddy's Lab

Dr. Reddy's laboratory is a pharmaceutical company established in India in the year 1984 by
Mr. Kallam Anji Reddy. It is headquartered in Hyderabad, Telangana. The company has over

8
 ORGANIZATION STUDY AT BPRL PVT. LTD.

190 various medications, 60 active APIs for drug manufacture, diagnostic kits, critical care
and biotechnology products. Dr. Reddy's is the fifth largest pharmaceutical company of India
with respect to it's revenue. It's revenue for the FY 2023 was at ₹24,846 Cr.

 Cipla

Cipla, also known as Chemical, Industrial & Pharmaceutical Laboratories, was established by
Mr. Khwaja Abdul Hamied in the year 1935. The company is the therapy leader in India for
anti-malarial with a market share of 34%. It is headquartered in Mumbai, Maharashtra. Cipla
is the fourth largest pharmaceutical company in India. Its total revenue for the FY 2020 was
calculated ₹9,500 Cr.

1.8 MARKET AND MARKET SHARE

BPRL operates in the Indian pharmaceutical market, which is the third-largest in the world by
volume and fourteenth-largest by value.

The Indian pharmaceutical market is expected to grow at a CAGR of 11% between 2023 and
2028, driven by factors like increasing healthcare awareness, rising disposable incomes, and
an aging population.

BPRL likely focuses on various segments within the Indian pharmaceutical market, including
generics, branded drugs, and biosimilars.

Unlisted company: Bangalore Pharmaceutical and Research Laboratory is a private unlisted

company. This means its financial information is not publicly available, making it difficult to
obtain the data needed for market share analysis.

1.9 BEST PRACTICES

 Quality Management:
 Adherence to GMP and international quality standards.
 Robust quality control systems throughout the manufacturing process.
 Continuous improvement and investment in quality management systems.

9
 ORGANIZATION STUDY AT BPRL PVT. LTD.

 Research and Development:

 Focus on developing innovative and affordable generic medications.
 Growing presence in the biosimilar market with high-quality products.
 Collaboration with leading universities and research institutions.
 Investment in cutting-edge technologies for research and development.

 Manufacturing:
 State-of-the-art manufacturing facilities designed to meet international standards.
 Highly skilled and experienced workforce.
 Adoption of efficient and cost-effective manufacturing processes.
 Focus on environmental sustainability and reducing waste.

 Supply Chain Management:

 Strong relationships with suppliers of high-quality raw materials.
 Efficient logistics and distribution network.
 Advanced inventory management systems to ensure timely delivery.

 Customer Focus:
 Commitment to providing high-quality products that meet customer needs.
 Responsive and efficient customer service, Competitive pricing strategies.
 Active engagement with healthcare professionals and patients.

 Compliance and Ethics:

 Strict adherence to all regulatory requirements.
 High ethical standards in business practices.
 Transparency and accountability in operations.

 Social Responsibility:
 Commitment to improving healthcare access and affordability.
 Investment in community development initiatives.
 Environmental sustainability practices.

10
 ORGANIZATION STUDY AT BPRL PVT. LTD.

A PESTEL analysis is a strategic framework used to assess the macro-environmental factors

that can impact an organization's performance and long-term success.

PESTEL Analysis of Bangalore Pharmaceutical and Research Laboratory PVT LTD

(BPRL).

PESTEL analysis is a framework used to analyse the macro-environmental factors that can
impact an organization. These factors can be categorized as:

2.1 POLITICAL FACTOR:

 Government support for pharmaceutical research and development: Indian

government initiatives like "Pharma Vision 2024" and "Make in India" aim to boost
domestic pharmaceutical production and R&D. This bodes well for BPRL.
 Price controls and regulations: The government's control over drug prices can limit
BPRL's profit margins for certain drugs.
 Intellectual property (IP) protection: Strengthening IP laws can encourage BPRL to
invest in innovation and protect its discoveries.

11
 ORGANIZATION STUDY AT BPRL PVT. LTD.

2.2 ECONOMICAL FACTOR:

 Rising healthcare spending: Increasing healthcare awareness and disposable incomes

in India are driving growth in the pharmaceutical market, creating opportunities for
BPRL.
 Competition from generic drugs: BPRL may face stiff competition from generic
manufacturers offering cheaper alternatives to its drugs.
 Dependence on exports: BPRL's dependence on exports can make it vulnerable to
fluctuations in international currency exchange rates and economic conditions.

2.3 SOCIAL FACTOR:

 Growing demand for affordable healthcare: BPRL can cater to this demand by
developing and manufacturing cost-effective drugs.
 Increasing awareness of preventive healthcare: This trend can drive demand for
BPRL's products focused on wellness and chronic disease management.
 Shifting consumer preferences towards natural and herbal remedies: BPRL can
capitalize on this trend by expanding its Ayurvedic and herbal product portfolio.

2.4 TECHNOLOGICAL FACTOR:

 Advancements in biotechnology and genomics: These advancements can help BPRL

develop personalized medicines and targeted therapies.
 Adoption of digital technologies: BPRL can leverage AI, Big Data, and automation to
improve R&D efficiency, supply chain management, and customer service.
 Telemedicine and e-pharmacies: These trends can expand BPRL's reach and
accessibility, especially in remote areas.

12
 ORGANIZATION STUDY AT BPRL PVT. LTD.

2.5 ENVIRONMENTAL FACTOR:

 Sustainability concerns: BPRL needs to adopt green practices in its manufacturing

processes and waste disposal to minimize its environmental impact.
 Regulations on hazardous materials: BPRL needs to comply with stricter regulations
on the use and disposal of hazardous materials used in drug development and
production.
 Climate change: Climate change can disrupt the supply chain of raw materials and
impact the production of certain drugs.

2.6 LEGAL FACTOR:

 Data privacy regulations: BPRL needs to comply with data privacy laws like HIPAA
and GDPR when collecting and handling patient data.
 Patent laws and regulatory approvals: BPRL needs to navigate complex patent laws
and obtain regulatory approvals for its new drugs before launch.
 Counterfeit drugs: BPRL needs to implement robust measures to combat the sale of
counterfeit versions of its drugs, which can damage its brand reputation.

By understanding these PESTEL factors, BPRL PVT LTD can develop strategies to
capitalize on opportunities, mitigate threats, and ensure its long-term success in the dynamic
pharmaceutical industry.

13
 ORGANIZATION STUDY AT BPRL PVT. LTD.

The SWOC analysis framework is a popular and effective tool used to analyse an
organization's Strengths, Weaknesses, Opportunities, and Threats. It provides a
comprehensive understanding of both the internal and external factors that may impact an
organization's success.

SWOC Analysis of Bangalore Pharmaceutical and Research Laboratory PVT LTD

(BPRL).

This analysis can help BPRL identify areas for improvement, make strategic decisions, and
seize competitive advantages.

3.1 STRENGTH:

 Strong R&D capabilities: BPRL has a dedicated research team with expertise in
various drug development areas.
 Established reputation: BPRL has a strong brand name and a reputation for quality
and innovation in the Indian pharmaceutical market.

14
 ORGANIZATION STUDY AT BPRL PVT. LTD.

 Diversified product portfolio: BPRL offers a wide range of pharmaceutical products

across various therapeutic segments.
 Cost-effective manufacturing: BPRL has efficient manufacturing facilities and a
strong understanding of cost-optimization strategies.
 Experienced leadership: BPRL has a team of experienced leaders with a proven
track record in the pharmaceutical industry.

3.2 WEAKNESS:

 Limited global presence: BPRL's presence in international markets is relatively

small compared to larger pharmaceutical companies.
 High dependence on domestic market: BPRL's revenue heavily relies on the Indian
market, making it vulnerable to economic fluctuations within the country.
 Limited marketing and branding budget: Compared to its competitors, BPRL may
have a smaller budget for marketing and branding activities, impacting its brand
visibility in international markets.
 Patent expirations for key drugs: BPRL faces the challenge of patent expirations for
some of its key drugs, which may lead to decreased revenue and increased
competition.
 Limited pipeline of innovative drugs: BPRL needs to invest more in R&D to
develop a strong pipeline of innovative drugs to sustain its growth in the long run.

3.3 OPPORTUNITIES:

 Growing healthcare market in India: The Indian healthcare market is expected to

grow at a significant rate, providing BPRL with vast opportunities for expansion.
 Increased government support for R&D: Government initiatives like "Make in
India" and "Pharma Vision 2024" can provide BPRL with funding and support for its
research activities.

15
 ORGANIZATION STUDY AT BPRL PVT. LTD.

 Rising demand for affordable healthcare: BPRL can cater to this demand by
developing and manufacturing cost-effective drugs, particularly for chronic diseases
prevalent in India.
 Adoption of digital technologies: BPRL can leverage digital tools like AI and Big
Data to improve its R&D efficiency, marketing campaigns, and customer service.
 Expanding into biosimilars and biologics: This market segment is expected to grow
rapidly, and BPRL's expertise in R&D can position it as a key player in this space.

3.4 CHALLENGES:

 Increased competition from generic drug manufacturers: BPRL faces stiff

competition from domestic and international companies offering cheaper alternatives
to its drugs.
 Stringent regulatory environment: The pharmaceutical industry is heavily
regulated, and BPRL needs to comply with stringent regulations for drug
development, manufacturing, and marketing.
 Intellectual property infringement: BPRL needs to protect its intellectual property
from potential infringement, especially in international markets.
 Fluctuations in foreign exchange rates: BPRL's reliance on exports can be affected
by fluctuations in foreign exchange rates, impacting its profitability.
 Economic slowdown: A global economic slowdown can lead to decreased demand
for pharmaceuticals, impacting BPRL's revenue.

By analysing its internal strengths and weaknesses, as well as the external opportunities and
threats, BPRL PVT LTD can develop strategies to leverage its strengths, overcome its
weaknesses, capitalize on opportunities, and mitigate threats. This will help BPRL PVT LTD
maintain its competitive edge and achieve its long-term growth goals.

16
 ORGANIZATION STUDY AT BPRL PVT. LTD.

Porter's Five Forces Analysis of Bangalore Pharmaceutical and Research Laboratory

PVT LTD (BPRL)

Porter's Five Forces is a framework used to analyse the competitive landscape of an industry
and determine the overall attractiveness of the market. Here's how we can apply this
framework to BPRL:

4.1 Threat of New Entrants:

Moderate: The pharmaceutical industry has significant barriers to entry, including high
capital requirements, complex regulatory processes, and lengthy R&D cycles. However, the
availability of generic drugs and the growing popularity of biosimilars can ease entry for
some competitors.

Factors: High R&D costs, stringent regulatory approvals, patent protection, brand loyalty.

17
 ORGANIZATION STUDY AT BPRL PVT. LTD.

4.2 Bargaining Power of Suppliers:

Low to Moderate: BPRL has a large supplier base for raw materials and manufacturing
equipment. This gives them some bargaining power, especially considering the availability of
alternative suppliers. However, the dependence on specialized suppliers for certain
components or technologies can increase their bargaining power.

Factors: Availability of alternative suppliers, concentration of suppliers, cost of switching

suppliers, importance of supplier inputs.

4.3 Bargaining Power of Buyers:

Moderate to High: BPRL operates in a market with several large buyers, including
pharmaceutical distributors, hospitals, and government agencies. This gives the buyers some
bargaining power, especially when negotiating prices. However, BPRL's strong brand
reputation and unique product offerings can help them command premium prices.

Factors: Number and size of buyers, concentration of buyers, buyer switching cost,
information availability, price sensitivity of buyers.

4.4 Threat of Substitutes:

Moderate: Generic drugs and traditional therapies can act as substitutes for BPRL's branded
drugs. However, BPRL's innovative products and strong brand reputation can create barriers
to substitution.

Factors: Availability and affordability of substitutes, switching costs for buyers, buyer
satisfaction with substitutes.

18
 ORGANIZATION STUDY AT BPRL PVT. LTD.

4.5 Competitive Rivalry:

High: The Indian pharmaceutical market is highly competitive, with several domestic and
international players vying for market share. This leads to intense competition on price,
quality, and innovation.

Factors: Number and size of competitors, differentiation of products and services, growth
rate of the industry, exit barriers.

While the pharmaceutical industry offers opportunities for growth, BPRL PVT LTD faces
challenges from intense competition, stringent regulations, and the threat of substitutes.
However, BPRL's strengths in R&D, manufacturing efficiency, and brand reputation can help
them navigate these challenges and succeed in the market.

19
 ORGANIZATION STUDY AT BPRL PVT. LTD.

The McKinsey 7-S Framework, developed in the 1970s by Robert Waterman, Tom Peters,
and Julian Richardson, is a tool used to analyse and improve organizational effectiveness. It
proposes that seven key internal factors need to be aligned and reinforced for an organization
to achieve its goals. These factors are categorized into two groups:

Hard S’s:

Strategy: The organization's overall direction and goals.

Structure: The formal reporting relationships and division of work within the organization.

Systems: The procedures, processes, and IT systems that support the organization's work.

Soft S’s:

Shared Values: The core beliefs and principles that guide the organization's behaviour.

Skills: The knowledge, abilities, and expertise of the organization's employees.

Style: The leadership style and decision-making approach of the management team.

Staff: The people who work in the organization, their capabilities, and motivation.

20
 ORGANIZATION STUDY AT BPRL PVT. LTD.

McKinsey's 7’S Framework for Bangalore Pharmaceutical and Research Laboratory

PVT LTD (BPRL)

McKinsey's 7’S Framework helps analyse an organization's internal environment and identify
areas for improvement across various dimensions. Let's apply this framework to BPRL:

5.1 STRATEGY:

 Vision: To be a leading pharmaceutical company in India, known for innovation,

quality, and affordability.
 Mission: To develop and deliver life-saving and life-enhancing medicines to people
around the world.
 Strategic priorities: Focus on R&D, expand into new markets, invest in digital
technologies, and build a strong brand reputation.
 Competitive advantage: Strong R&D capabilities, cost-effective manufacturing, and
established brand name.

5.2 STRUCTURE:

 Organizational structure: Hierarchical structure with centralized decision-making.

 Departments: R&D, manufacturing, marketing, finance, and human resources.
 Reporting lines: Clearly defined reporting lines to ensure accountability.
 Cross-functional collaboration: Encouraged through project teams and committees.

21
 ORGANIZATION STUDY AT BPRL PVT. LTD.

BOARD OF
DIRECTORS

CHIEF
EXECUTIVE
OFFICER

ADMINISTRA
MARKETING OPERATION
TION

MANUFACTU
SALES FINANCE
RING

RESEARCH AND HUMAN

ADVERTISING DEVELOPMENT RESOURCE

QUALITY SUPPLY CHAIN

MANAGMENT
LEGAL
ASSURANCE

5.3 SYSTEMS:

 Information technology systems: ERP system for managing financial data, inventory,
and supply chain.
 Quality management systems: Comply with GMP (Good Manufacturing Practice) and
regulatory standards.
 R&D processes: Structured and efficient processes for drug development and testing.
 Performance metrics: Track key metrics like R&D productivity, market share, and
profitability.

22
 ORGANIZATION STUDY AT BPRL PVT. LTD.

5.4 SKILLS:

 Innovation: Commitment to developing new and innovative drugs.

 Quality: Dedication to delivering high-quality products and services.
 Customer focus: Focus on meeting the needs and expectations of customers.
 Ethical conduct: Commitment to ethical business practices and corporate social
responsibility.

5.5 STAFF:

 Scientific expertise: Strong team of scientists and researchers with expertise in

various fields.
 Manufacturing skills: Skilled workforce with experience in pharmaceutical
manufacturing processes.
 Marketing and sales skills: Experienced team for marketing and selling BPRL's
products.
 Management skills: Leaders with strong business acumen and leadership capabilities.

5.6 STYLE:

 Decision-making: Top-down decision-making with input from senior management.

 Leadership style: Authoritative but open to feedback and suggestions.
 Communication style: Clear and concise communication within and across
departments.
 Work culture: Collaborative and performance-oriented work culture.

5.7 SHARED VALUES:

 Employee engagement: High levels of employee engagement and satisfaction.

 Talent management: Focus on attracting, developing, and retaining top talent.
 Diversity and inclusion: Committed to creating a diverse and inclusive workplace.
 Learning and development: Invest in employee training and development programs.

23
 ORGANIZATION STUDY AT BPRL PVT. LTD.

Analysis:

BPRL has a strong foundation across all seven elements of the 7-S framework. However,
there are some areas where BPRL PVT LTD can improve:

• Increase agility and flexibility: To adapt to the changing market landscape, BPRL can
explore flatter organizational structures and empower teams for faster decision-
making.
• Enhance digital capabilities: Investing in advanced analytics, AI, and automation can
improve R&D efficiency, marketing effectiveness, and supply chain management.
• Foster a more entrepreneurial culture: Encourage employee innovation and risk-taking
to drive faster development and new business ventures.
• Strengthen global mind set: As BPRL expands internationally, developing a more
global mind set and cultural sensitivity is crucial for success in diverse markets.

By addressing these areas for improvement, BPRL can further strengthen its internal
environment and ensure sustainable growth in the competitive pharmaceutical industry.

24
 ORGANIZATION STUDY AT BPRL PVT. LTD.

CONCLUSION

Based on the various analyses conducted, including PESTEL, SWOT, Porter's Five Forces,
and McKinsey's 7-S framework, we can reach the following conclusions about BPRL:

BPRL PVT LTD is a well-established pharmaceutical company with a strong foundation for
growth. However, the competitive landscape and evolving market dynamics require BPRL to
continuously adapt and innovate to maintain its competitive edge.

Recommendations:

 Focus on R&D and develop a robust pipeline of innovative drugs.

 Expand into international markets and emerging segments like biosimilars and
biologics.
 Invest in digital technologies to improve efficiency and effectiveness across various
operations.
 Strengthen brand reputation and increase marketing efforts to build stronger customer
loyalty.
 Foster a culture of innovation and agility to adapt to changing market conditions.
 Develop a global mindset and cultural sensitivity to succeed in international markets.

By implementing these recommendations and leveraging its strengths, BPRL can overcome
its challenges and achieve its long-term vision of becoming a leading pharmaceutical
company both in India and on the global stage.

25
 ORGANIZATION STUDY AT BPRL PVT. LTD.

LEARNING EXPIERENCE

At the foremost, I would like to extend my thanks to the BPRL Pvt Ltd for giving me this
opportunity to conduct the subject Organization Study in the company. I would also like to
thank Mrs. Vedavathi K R for helping and guiding me to prepare this report and being co-
operative during my internship study.

I would like to further thank all the employees of BPRL Pvt. Ltd. who have helped me in
completion of this report.

Further, my humble thanks to SURANA COLLEGE (Autonomous) for implementing the

subject project in the curriculum. It was an inspiring, eye opening and an educating
experience.

This project has helped me in understanding the structural hierarchy as well as the
organizational actions in depth. Further, it has also helped me in understanding the work flow
of all the departments of the company and their interdependence on one another.

The Company graciously allowed me to implement my classroom knowledge courtesy of this

reputed Institution; into the reality of organizational management. I experienced the work
flow of any organization in its systematic manner that can efficiently make the company's
objectives more effortless to achieve.

Finally, it could wholeheartedly be said that it was an instructive experience to complete this
project with the knowledge that can surely be helpful in the future.

26
 ORGANIZATION STUDY AT BPRL PVT. LTD.

REFERENCES

WEBSITES:
1) https://www.bprl.in/
2) https://www.ibef.org/industry/pharmaceutical-india.aspx
3) https://en.wikipedia.org/wiki/Pharmaceutical industry in India

27
 ORGANIZATION STUDY AT BPRL PVT. LTD.

Surana College (Autonomus)

Kengeri, Satellite Town

Bengaluru – 560060

Department of MBA

Progress Report – 1

Sl. No. Particulars

1 Name of the Student M M SUJITH

2 Registration Number P03ME22M015120
3 Name of the College Guide Prof. Suma B R
4 Name of the Company’s Guide Mrs K R Vedavathi
Phone No:
9844854113
Email Id: accounts@bprl.in
5 Title of the project Organisation Study at BPRL Pvt Ltd
6 Progress report: A brief note
reflecting, Number of meetings Discussed about PESTEL analysis and
with Guides, places visited, SWOC analysis. Visited library for
libraries visited, books referred, collecting information about the related
meeting with persons, activities topics.
taken up, preparations done for
collection and analysis of data
etc.,

Date:

Signature of the candidate Signature of the college guide

28
 ORGANIZATION STUDY AT BPRL PVT. LTD.

Surana College (Autonomus)

Kengeri, Satellite Town

Bengaluru – 560060

Department of MBA

Progress Report – 2

Sl. No. Particulars

1 Name of the Student M M SUJITH

2 Registration Number P03ME22M015120
3 Name of the College Guide Prof. Suma B R
4 Name of the Company’s Guide Mrs K R Vedavathi
Phone No:
9844854113
Email Id: accounts@bprl.in
5 Title of the project Organisation Study at BPRL Pvt Ltd
6 Progress report: A brief note
reflecting, Number of meetings External guide also helped me with the
information needed for report. Discussed
with Guides, places visited,
about Porter’s five forces model and
libraries visited, books referred, McKinsey’s 7’s framework model.
meeting with persons, activities
taken up, preparations done for
collection and analysis of data
etc.,

Date:

Signature of the candidate Signature of the college guide

29
 ORGANIZATION STUDY AT BPRL PVT. LTD.

Surana College (Autonomus)

Kengeri, Satellite Town

Bengaluru – 560060

Department of MBA

Progress Report – 3

Sl. No. Particulars

1 Name of the Student M M SUJITH

2 Registration Number P03ME22M015120
3 Name of the College Guide Prof. Suma B R
4 Name of the Company’s Guide Mrs K R Vedavathi
Phone No:
9844854113
Email Id: accounts@bprl.in
5 Title of the project Organisation Study at BPRL Pvt Ltd
6 Progress report: A brief note
reflecting, Number of meetings Hence the guide helped me with the
corrections needed and report completion.
with Guides, places visited,
Also gained knowledge about the
libraries visited, books referred, company as to how they work and what
are the merits and demerits.
meeting with persons, activities
taken up, preparations done for
collection and analysis of data
etc.,

Date:

Signature of the candidate Signature of the college guide

30